Claritev Corporation (CTEV) Research

Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.

Market snapshot

Symbol
CTEV
Price
$29.42
Day change
-1.11%
Market cap
$501.5M
P/E ratio
-1.71x
52-week range
11.5-74.07
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 2 months
Analyst price target
$39.25

Recent news

  • The High-Yield Stocks the Smart Money Is Buying Right Now

    There is a principle I have followed for 30 years in this business. When the smartest credit team on the planet starts aggressively buying a beaten-down asset class they understand better than anyone alive, you do not sit on your hands and debate whether the timing is perfect.

Peer companies

  • AxoGen, Inc. (AXGN)
  • Dianthus Therapeutics, Inc. (DNTH)
  • Evolent Health, Inc. (EVH)
  • GoodRx Holdings, Inc. (GDRX)
  • Integra LifeSciences Holdings Corporation (IART)
  • InMode Ltd. (INMD)
  • IRadimed Corporation (IRMD)
  • LifeMD, Inc. (LFMD)

Recent insider activity

  • Carol Nutter — P-Purchase (875 shares) on 2026-06-09
  • Kim Michael — P-Purchase (3000 shares) on 2026-05-18
  • Prince John Michael — P-Purchase (10000 shares) on 2026-05-19
  • Dalton Travis — P-Purchase (11200 shares) on 2026-05-18
  • Dalton Travis — P-Purchase (9720 shares) on 2026-05-18

Open Claritev Corporation (CTEV) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.